Covered recipient · General Payments record
MICHAEL L EMERY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,498.37
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $441.62 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teleflex LLC | $206.41 | 5 |
| Antares Pharma, Inc. | $76.95 | 4 |
| Endo USA, Inc. | $51.53 | 3 |
| COLOPLAST CORP | $42.83 | 2 |
| TOLMAR, INC. | $25.97 | 1 |
| Telix Pharmaceuticals | $23.27 | 1 |
| Janssen Biotech, Inc. | $14.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $18.75 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146503718 | CMS |
| Antares Pharma, Inc. | $20.37 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146503722 | CMS |
| Antares Pharma, Inc. | $20.05 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146503726 | CMS |
| Antares Pharma, Inc. | $17.78 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146503730 | CMS |
| COLOPLAST CORP | $21.98 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440028 | CMS |
| COLOPLAST CORP | $20.85 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117440088 | CMS |
| Endo USA, Inc. | $15.57 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138592382 | CMS |
| Endo USA, Inc. | $18.57 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138592384 | CMS |
| Endo USA, Inc. | $17.39 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138592386 | CMS |
| Janssen Biotech, Inc. | $14.66 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078417707 | CMS |
| Teleflex LLC | $22.18 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142097187 | CMS |
| Teleflex LLC | $32.93 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142088628 | CMS |
| Teleflex LLC | $118.01 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142080188 | CMS |
| Teleflex LLC | $18.01 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142080186 | CMS |
| Teleflex LLC | $15.28 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142075903 | CMS |
| Telix Pharmaceuticals | $23.27 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986636 | CMS |
| Tolmar, Inc. | $25.97 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138706030 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.